Comparison of DNA damage and proliferative capacities in smear samples of HPV positive and negative patients by micronucleus counting and AgNOR staining

References

• Adam ML, Pini C, Tulio S, Cantalice JCLL, Torres RA, Correia MTDS. 2015. Assessment of the association between micronuclei and the degree of uterine lesions and viral load in women with human papillomavirus. Cancer Genom-Proteom. 12:67–71.
   PubMed Web of Science ®Google Scholar
• Ambroise MM, Balasundaram K, Phansalkar M. 2013. predictive value of micronucleus count in cervical intraepithelial neoplasia and carcinoma. Turk J Pathol. 29:171–178.
   Google Scholar
• Ault KA. 2006. Epidemiology and natural history of human papillomavirus infections in the female genital tract. Infect Dis Obstet Gynecol. (2006:40470.
   PubMedGoogle Scholar
• Bodner-Adler B, Kimberger O, Schneidinger C, Koelbl H, Bodner K. 2016. Prognostic significance of pre-treatment serum c-reactive protein level in patients with adenocarcinoma of the uterine cervix. Anticancer Res. 36:4691–4696.
   PubMed Web of Science ®Google Scholar
• Cassel APR, Barcellos RB, Silva CMDD, Almeida SE, d M, Rossetti MLR. 2014. Association between human papillomavirus (HPV) DNA and micronuclei in normal cervical cytology. Genet Mol Biol. 37:360–363.
   PubMed Web of Science ®Google Scholar
• Cheng S, Schmidt-Grimminger D-C, Murant T, Broker TR, Chow LT. 1995. Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev. 9:2335–2349.
   PubMed Web of Science ®Google Scholar
• Cortés-Gutiérrez E, Dávila-Rodríguez M, Vargas-Villarreal J, Hernández-Garza F, Cerda-Flores R. 2010. Association between human papilloma virus-type infections with micronuclei frequencies. Prague Med Rep. 111:35–41.
   PubMedGoogle Scholar
• Crook T, Vousden KH, Tidy JA. 1991. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell. 67:547–556.
   PubMed Web of Science ®Google Scholar
• De Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, Bosch FX. 2007. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 7:453–459.
   PubMed Web of Science ®Google Scholar
• Duensing S, Münger K. 2004. Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int J Cancer. 109:157–162.
   PubMed Web of Science ®Google Scholar
• Dursun P, Senger SS, Arslan H, Kuşçu E, Ayhan A. 2009. Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit. BMC Infect Dis. 9:191–197.
   PubMed Web of Science ®Google Scholar
• Ferlay J (2001). GLOBOCAN 2000. Cancer incidence, mortality and prevalence worldwide, version 1.0. IARC Cancerbase.
   Google Scholar
• Gašperov NM, Sabol I, Matovina M, Spaventi Š, Grce M. 2008. Detection and typing of human papillomaviruses combining different methods: polymerase chain reaction, restriction fragment length polymorphism, line probe assay and sequencing. Pathol Oncol Res. 14:355–363.
   PubMed Web of Science ®Google Scholar
• Gill G. 2012. Cytopreparation: principles and practice. New York: Springer Science and Business Media. Vol. 12 p. 143–189.
   Google Scholar
• He X, Li J-P, Liu X-H, Zhang J-P, Zeng Q-Y, Chen H, Chen S-L. 2018. Prognostic value of C-reactive protein/albumin ratio in predicting overall survival of Chinese cervical cancer patients overall survival: comparison among various inflammation based factors. J Cancer. 9:1877–1884.
   PubMed Web of Science ®Google Scholar
• Hidalgo J, Rocher A, López J, Gamboni M, Vighi S, Canessa OE, Perssini S, Guerra F, Di Carlo MB, Palaoro L. 2012. AgNOR, p16 and human papillomavirus in low-grade squamous intra-epithelial lesions of the uterine cervix. Preliminary report. Biotech Histochem. 87:257–264.
   PubMed Web of Science ®Google Scholar
• Hoory T, Monie A, Gravitt P, Wu T-C. 2008. Molecular epidemiology of human papillomavirus. J Formosan Med Assoc. 107:198–217.
   PubMed Web of Science ®Google Scholar
• Inal M, Köse Ş, Yildirim Y, Özdemir Y, Töz E, Ertopçu K, Özelmas İ, Tinar Ş. 2007. The relationship between human papillomavirus infection and cervical intraepithelial neoplasia in Turkish women. Int J Gynecol Cancer. 17:1266–1270.
   PubMed Web of Science ®Google Scholar
• Johnson-Obaseki S, Caulley L, Corsten M, Liu G, Dimitroulakos J, Goldstein D, Irish J, Rider J. 2019. C-reactive protein in HPV-positive and HPV-negative oropharyngeal cancer. Otolaryngol Head Neck Surg. 160:494–501.
   PubMed Web of Science ®Google Scholar
• Lehucher-Michel M, Amara-Mokrane YA, Devictor B, Catilina P, Botta A. 1996. Micronuclei kinetics of exfoliated urothelial cells. Muta Res Fund Mol Mech Mutagen. 354:1–7.
   PubMed Web of Science ®Google Scholar
• Lindner LE. 1993. Improvements in the silver-staining technique for nucleolar organizer regions (AgNOR). J Histochem Cytochem. 41:439–445.
   PubMed Web of Science ®Google Scholar
• McLaughlin-Drubin ME, Münger K. 2009. Oncogenic activities of human papillomaviruses. Virus Res. 143:195–208.
   PubMed Web of Science ®Google Scholar
• Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108.
   PubMed Web of Science ®Google Scholar
• Parkin DM, Bray F. 2006. The burden of HPV-related cancers. Vaccine. 24:S11–S25.
   Web of Science ®Google Scholar
• Polterauer S, Grimm C, Seebacher V, Rahhal J, Tempfer C, Reinthaller A, Hefler L. 2010. The inflammation-based Glasgow Prognostic Score predicts survival in patients with cervical cancer. Int J Gynecol Cancer. 20:1052–1057.
   PubMed Web of Science ®Google Scholar
• Polterauer S, Grimm C, Zeillinger R, Heinze G, Tempfer C, Reinthaller A, Hefler L. 2011. Association of C-reactive protein (CRP) gene polymorphisms, serum CRP levels and cervical cancer prognosis. Anticancer Res. 31:2259–2264.
   PubMed Web of Science ®Google Scholar
• Schiffman M, Castle PE. 2003. Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med. 127:930–934.
   PubMed Web of Science ®Google Scholar
• Srivastava AN, Misra JS, Singh U, Khan M, Raza S. 2019. AgNOR pleomorphic count as a tumor marker in cervical carcinogenesis and feasibility of its introduction in cervical cancer screening programs to discriminate high-risk cases of squamous intraepithelial lesions of the cervix. Acta Cytol. 63:371–378.
   PubMed Web of Science ®Google Scholar
• Trere D. 2000. AgNOR staining and quantification. Micron. 31:127–131.
   PubMed Web of Science ®Google Scholar